Prof John G Gribben Consultant Profile
Professor John Gribben, MD, DSc, FMedSci currently leads the Centre for Haemato-Oncology at Barts Cancer Institute at Queen Mary, University of London, UK, where he holds the Gordon Hamilton Fairley Chair of Medical Oncology. He is an honorary consultant in haemato-oncology and has served as director of the Stem Cell Transplantation and Immune Effector Cell Program at St Bartholomew’s Hospital, Barts Health NHS Trust for the past 20 years.
He completed his doctoral studies at University College London and at Harvard Medical School and continued his postdoctoral training in medical oncology and then joined the Faculty at the Dana-Farber Cancer, Harvard Medical School, Boston Massachusetts, USA.
He is an author of more than 575 articles and chapters in peer-reviewed publications. He was a founding member of the CLL Research Consortium and was awarded the Binet-Rai medal for CLL research from iwCLL in 2017. He served as an Editor of Blood from 2007 to 2014. He is a Fellow of the Royal College of Physicians, and the Royal College of Pathologists. He was elected as a member of the American Society for Clinical Investigation and a Fellow of the Academy of Medical Science. He is Chair of the international workshop on non-Hodgkin’s Lymphoma (iwNHL) and also served as chair of the international workshop for CAR-T cells (iwCART). He was President of the European Hematology Association from 2019-2021. He was awarded the prestigious Jose Carreras Career Development Medal acknowledging his lifetime contributions to research in haematologic malaignancies in 2024.